| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.39 | 6e-08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-05 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.0001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0007 |